"More than a third of Parkinson's patients suffer from dementia," Prof Dr Heinz Reichmann told more than 3,000 experts gathered at the 23rd Meeting of the European Neurological Society (ENS) in Barcelona to discuss the latest developments in the field. Prof Reichmann (University Hospital Carl...
New research reveals that Solanaceae - a flowering plant family with some species producing foods that are edible sources of nicotine - may provide a protective effect against Parkinson's disease. The study appearing in Annals of Neurology, a journal of the American Neurological Association and...
Last month, the National Institutes of Health announced a new collaborative initiative that aims to accelerate the search for biomarkers -- changes in the body that can be used to predict, diagnose or monitor a disease -- in Parkinson's disease, in part by improving collaboration among...
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the most common genetic mutations in familial Parkinson's disease damage brain cells. The study, which published online in the journal Nature Neuroscience, could also open up treatment possibilities for...
Phytopharm plc (PYM: London Stock Exchange) ("Phytopharm", the "Group" or the "Company") have announced the results of the Phase II, randomised, double blind, placebo controlled, dose-ranging trial of Cogane™ in unmedicated patients with early-stage Parkinson's disease ("CONFIDENT-PD"). Analysis...
New research from the US finds the action of three gene variants already linked with Parkinson's may contribute to a defect in how brain cells move internal proteins around. The discovery could help explain the cause of, and point to treatment for, the common, non-familial form of the disease...
A "small stroke", also known as a "silent stroke" can cause Parkinson's disease - this explains why some people who are outwardly health may develop the disease. Researchers from the Faculty of Life Sciences at the University of Manchester, England, explained in the journal Brain Behavior and...
Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson University researchers report in a new study published online in the Journal of the Neurological Sciences. Although...
Prion diseases represent a family of neurodegenerative disorders associated with the loss of brain cells and caused by proteins called prions (derived from 'protein' and 'infection'). The diseases are found in both humans and animals, such as Creutzfeld-Jakob disease and mad cow disease...
A new imaging technique developed at MIT offers the first glimpse of the degeneration of two brain structures affected by Parkinson's disease. The technique, which combines several types of magnetic resonance imaging (MRI), could allow doctors to better monitor patients' progression and track...
Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. Now, after several years of incremental study, researchers at the Perelman School of...
During the past year, the research group TIC 218 at the Department of Signal Theory, Telematics and Communications attached to the University of Granada and the Andalusian Information Technology and Communications Center (CITIC) has implemented the methods for the detection and diagnosis of...
Parkinson's disease is a degenerative disorder of the central nervous system characterized by shaking, rigidity, slowness of movement and difficulty with walking and gait and later on, often by cognitive and behavioral problems. British Columbia University researchers have discovered that the...
Parkinson's disease is the second leading neurodegenerative disease after Alzheimer's disease. Now, researchers at The Technical Research Centre for Dependency, Care and Autonomous Living (CETpD) of the Universitat Politècnica de Catalunya, BarcelonaTech (UPC) have designed a new wearable...
A "one-size-fits-all" new class of drugs that targets a particular type of brain inflammation is showing early promise for the treatment of Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury. A pre-clinical study due to be published this week in the...
University of California, San Diego scientists have used powerful computational tools and laboratory tests to discover new support for a once-marginalized theory about the underlying cause of Parkinson's disease. The new results conflict with an older theory that insoluble intracellular fibrils...
A major 12-year study based on a Taiwanese population cohort has demonstrated that not only does diabetes increase the risk of developing Parkinson's disease more than 2-fold, the use of sulfonylureas, commonly used as treatment for diabetes, increases the risk further by about 57%. This study...
Men who eat flavonoid-rich foods such as berries, tea, apples and red wine significantly reduce their risk of developing Parkinson's disease, according to new research by Harvard University and the University of East Anglia (UEA). Published in the journal Neurology ®, the findings add to the...
Men who regularly consume foods rich in flavonoids, such as berries, apples, certain vegetables, tea and red wine, may significantly reduce their risk for developing Parkinson's disease, according to a study published in the journal Neurology this week that saw no such effect among women...